Rochester, United States
Research view
Neuroendocrine tumours: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
- All targets
- PD-1 1
- BRAF 0
- TP53 1
- PD-L1 0
- DLL3 14
- PI3K 0
- CTLA-4 0
- mTOR 1
- STAT3 0
- AKT 0
- MEK 0
- MAPK 0
- VEGF 1
- RET 0
- ERK 0
- STING 0
- YAP 0
- PRAME 0
- CTNNB1 0
- NRAS 0
- BAP1 0
- PTEN 0
- ALK 0
- EGFR 1
- MYC 0
- CXCR4 0
- EZH2 0
- HIF-1 0
- HSP90 0
- JNK 0
- PARP 5
- PSMA 3
- TNF 0
- CD40 0
- CDK4/6 0
- GPX4 0
- NRF2 0
- VHL 3
- AMPK 0
- B7-H3 2
- COX-2 0
- KRAS 0
- PPAR 0
- CD47 1
- KIT 1
- RAS 0
- TERT 0
- BRCA2 0
- CDKN2A 0
- GLP-1 0
- HER2 1
- IGF1R 0
- IL-17 0
- LAG-3 0
- MET 0
- MMP-9 0
- RB1 1
- TIGIT 0
- TROP2 1
- AXL 0
EU-13 is a filter, not a ranking: it only narrows the list.
Memorial Sloan Kettering Cancer Center · New York, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Histopathology, Jan 2026Analysis of SCLC subtype markers (ASCL1, NEUROD1, POU2F3, YAP1), DLL3, OTP, and TTF1 in 300 lung carcinoids and enteropancreatic neuroendocrine tumours.
St Louis, United States
Boston, United States
Tampa, United States
Fudan University Shanghai Cancer Center · Shanghai, China
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Cell Death Dis, Dec 2025Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors.
Madrid, Spain
Atlanta, United States
Massachusetts General Hospital · Boston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Histopathology, Nov 2025Transcription factor-based subtype assignment in pulmonary large cell neuroendocrine carcinoma.
Columbus, United States
Madrid, Spain
New Haven, United States
Barcelona, Spain
Portland, United States
Villejuif, France
Milan, Italy
Columbus, United States
Tokyo, Japan
Seoul, South Korea
Beijing, China
Evanston, United States
Samsung Medical Center · Seoul, South Korea
Team details appear once the team leader joins.
Is this your team? Claim it
Latest publication · Cancer Med, Jan 2026Tumor Control After Radiosurgery in Sporadic and Neurofibromatosis Type 2 Vestibular Schwannomas.
Seoul, South Korea
23 of 23+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 50
- Organoids 14
- Mendelian Randomization Analysis 6
- CRISPR-Cas Systems 13
- Gene Expression Profiling 118
- Sequence Analysis, RNA 8
- Whole Genome Sequencing 10
- Exome Sequencing 13
- Proteomics 49
- Metabolomics 20
- Mass Spectrometry 4
- Flow Cytometry 55
- Immunohistochemistry 185
- Liquid Biopsy 9
- Circulating Tumor DNA 35
- Xenograft Model Antitumor Assays 117
- Positron-Emission Tomography 61
- Magnetic Resonance Imaging 200
- Machine Learning 53
- Deep Learning 53
- Cohort Studies 80
- Genome-Wide Association Study 12
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.